Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0043167 (
pertussis
)
19,595
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A 60-year-old heterosexual man with AIDS was admitted to hospital with dyspnea, a severe paroxysmal
non-productive cough
of two months' duration, low-grade fever and exhaustion. Bordetella
pertussis
was cultured from a bronchoalveolar lavage specimen. After erythromycin therapy (500 mg q.i.d. for two weeks) all respiratory symptoms resolved progressively over a four-week period. Bordetella
pertussis
should be added to the long list of pathogens that may cause respiratory disease in persons with HIV infection.
...
PMID:Bordetella pertussis as a cause of chronic respiratory infection in an AIDS patient. 807 Apr 37
This case highlights the difficulties associated with the differential diagnosis of pulmonary symptoms in patients with pre-existing diseases in extreme environmental conditions. A 58-year-old man with child-onset allergic asthma developed dyspnoea and an acute
non-productive cough
during a trekking expedition on Mt. Kilimanjaro (5895m) in Tanzania. The symptoms were believed initially to be linked to the high altitude exposure (high altitude pulmonary oedema (HAPE) or high altitude cough) or his pre-existing asthma. However, he was later diagnosed correctly with a reinfection of Bordetella
pertussis
.
Pertussis
is a highly communicable disease with potentially serious medical consequences that could have affected all of the expedition members. The effectiveness of a
pertussis
vaccine declines 4-12 years after the vaccination. Thus, it is suggested that the status of immunisation against
pertussis
should be checked along with those of other infections prior to travel.
...
PMID:Cough and dyspnoea of an asthmatic patient at Mt. Kilimanjaro: a difficult differential diagnosis. 2018 1